Anavex Life Sciences Ratios and Metrics

Market cap in millions EUR. Fiscal year is October - September.

Millions EUR. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 20, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Market Capitalization	324	652	432	507	820	1,173
Market Cap Growth	-55.47%	50.88%	-14.85%	-38.17%	-30.06%	402.86%
Enterprise Value	212	565	307	361	664	1,037
Last Close Price	3.39	7.25	4.96	6.35	9.69	15.20
PB Ratio	3.01	8.06	4.01	3.78	5.65	9.01
P/TBV Ratio	3.01	8.06	4.01	3.78	5.65	9.01
Net Debt / Equity Ratio	-1.04	-1.08	-1.10	-1.06	-1.05	-1.01
Quick Ratio	20.81	11.56	8.80	12.27	14.92	14.93
Current Ratio	20.87	11.61	8.86	12.32	14.95	14.97
Return on Equity (ROE)	-33.63%	-43.11%	-32.81%	-33.41%	-32.71%	-42.58%
Return on Assets (ROA)	-21.56%	-26.51%	-21.81%	-21.59%	-18.95%	-23.87%
Return on Capital Employed (ROCE)	-35.00%	-53.50%	-42.10%	-37.40%	-33.40%	-24.80%
Earnings Yield	-10.50%	-6.07%	-8.93%	-8.85%	-5.96%	-2.79%
Buyback Yield / Dilution	-2.61%	-2.18%	-4.61%	-3.74%	-10.18%	-19.95%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.